Efruxifermin, an investigational treatment for fibrotic or cirrhotic nonalcoholic steatohepatitis (NASH)

  • Tobias Puengel
  • , Frank Tacke

Research output: Contribution to journal › Review article › peer-review

22 Scopus citations

Fingerprint

Dive into the research topics of 'Efruxifermin, an investigational treatment for fibrotic or cirrhotic nonalcoholic steatohepatitis (NASH)'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science